SweetValueLab
Write for us

Baxter International Inc. — Intrinsic Value & Fair Price

BAX
NYSEHealthcareMedical - Instruments & SuppliesCIK 0000010456baxter.comAbout BAX
Valuation grade ?–not graded
Quant grade ?C
Last close · Oct 30, 202623.00−0.50 (−2.13%)

Valuation models

price $23.00 · as of Nov 2, 2026
EV/Revenue · peersused15.77 – 26.4623.341% undervaluedWall St. consensus target—22.502% aboveCost of capital (WACC)—6.19%—

EV/Revenue · peers leads because DCF · Perpetuity growth · 5y could not lead: the cash-flow gate is shut (an operating loss, or three years of free cash flow summing below zero); P/E · peers does not describe this kind of business; EV/EBITDA · peers could not run on the filed statements. How the headline model is chosen.

engine build:07a9d3f952ed
Model value · EV/Revenue · peers
23.34
Baxter International closed at $23.00 — undervalued by 1% vs model.
15.77the model's range26.46

EV/Revenue · peers leads because DCF · Perpetuity growth · 5y could not lead: the cash-flow gate is shut (an operating loss, or three years of free cash flow summing below zero); P/E · peers does not describe this kind of business; EV/EBITDA · peers could not run on the filed statements. From its peers' median EV/Revenue.

Other models
—
Wall St. target
22.50 2% above
Below model, 1y
17 of 30 days

How it is valued

Valued asMature & stable
Low/slowing growth (~4% recent)Currently unprofitablePays dividendsHighly cyclical earnings
What growth the price implies: the reverse DCF

Model estimates for research reference only, not investment advice. Every model rests on assumptions that may not match what happens; how each model works is in the manual.